to experience the full functionality of mail.com.
Enhanced by Google
Merck & Co Inc
October 27, 2016
Bid to speed transplants with hepatitis C-infected kidneys
Some patients facing a years-long wait for a kidney transplant are jumping ahead in line thanks to a startling experiment: ...
October 25, 2016
Merck breezes past 3Q profit expectations, raises forecast
Higher sales of vaccines and prescription medicines, coupled with restrained spending, helped Merck & Co. post a 20 percent ...
October 20, 2016
Preteens need only 2 HPV shots _ not 3, CDC says
It's now easier for preteens to get the cervical cancer vaccine. The government on Wednesday quickly adopted a recommendation ...
August 05, 2016
US stocks rise to record highs after strong jobs report
U.S. stocks jumped to record highs Friday after a strong jobs report for the month of July gave investors more confidence ...
August 05, 2016
Bristol-Myers drug fails lung cancer study, shares plunge
A blockbuster cancer treatment failed in a key study as the drug's maker, Bristol-Myers Squibb, attempts to extend its usage ...
July 29, 2016
Merck posts strong 2Q numbers, while building for long term
Drugmaker Merck & Co., focused heavily on its long-term future as it builds sales of crucial new medicines Keytruda for ...
June 28, 2016
FDA approves first pill to treat all forms of hepatitis C
Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series ...
June 10, 2016
Merck to buy biotech drug developer Afferent Pharmaceuticals
Drugmaker Merck is buying Afferent Pharmaceuticals, a privately held biotechnology company developing a chronic cough ...
May 05, 2016
Merck beats 1Q profit views with tight cost controls
Merck posted an 18 percent jump in first-quarter income, beating Wall Street expectations, as reduced spending on marketing, ...